Clinical Analysis of Operative treatment of Remnant Gastric Cancer.
- Author:
Kwang Ho LEE
1
;
Jong Inn LEE
;
Ho Yoon BANG
;
Woo Chul NOH
;
Dae Yong HWANG
;
Dong Wook CHOI
;
Nam Sun PAIK
;
Nan Mo MOON
Author Information
1. Department of General Surgery, Korea Cancer Center Hospital, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Remnant gastric cancer;
Survival
- MeSH:
Adenocarcinoma;
Diagnosis;
Female;
Gastrectomy;
Humans;
Incidence;
Korea;
Male;
Medical Records;
Prognosis;
Retrospective Studies;
Sex Ratio;
Spleen;
Stomach Neoplasms*;
Survival Rate
- From:Journal of the Korean Cancer Association
1999;31(5):964-971
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Authors analyzed the clinico-pathologic parameters of 34 remnant gastric cancers to know the general behavior and prognosis of remnant gastric cancer. MATERIALS AND METHODS: Medical records of 34 patients were reviewed retrospectively, who were diagnosed as remnant gastric adenocarcinoma and underwent operation in Korea Cancer Center Hospital from February of 1988 to March of 1998. RESULTS: The incidence of remnant gastric cancer was 0.7% (34/4,904 cases). Sex ratio, male to female, was 2.8: 1. Mean age was 55 years of age. Diagnoses of primary lesion were 10 cases of benign lesion, 24 cases of malignant lesion. The operation for the remnant gastric cancer is total gastrectomy or extended total gastrectomy. The most common extended-resected organ was spleen (21 cases). The morbidity following operation of remnant gastric cancer were quite rare and treated conservatively. The overall five year survival rate was 11.3%. CONCLUSION: Authors concluded that aggressive operation of remnant gastric cancer is warranted, as it is proved relatively safe and is the only option to lengthen patients survival and to alleviate their QOL (quality of life).
